FHLC ETF Analysis: Fidelity Health Care Index | NYSE
Health | NYSE, USA | Market Cap: 3.476m USD | 12M Return: 26.4% | US3160926008 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 18.5M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Fidelity MSCI Health Care Index ETF (FHLC) is a passively managed exchange-traded fund that seeks to track the performance of the MSCI USA IMI Health Care 25/50 Index, which measures the U.S. health care equity sector. Under its investment policy, at least 80% of the funds assets are held in securities included in the underlying index, though the fund may hold a representative sample rather than every constituent. FHLC is classified as non-diversified and was launched in October 2013.
The U.S. health care sector encompasses a diverse range of industries, including pharmaceuticals, biotechnology, medical devices, health insurers, and health care facilities and services. The 25/50 designation in the index name refers to diversification rules under the Investment Company Act of 1940, which limit the weighting of any single issuer to no more than 25% and cap aggregate issuer weights to comply with regulated investment company concentration limits.
- Drug pricing reform legislation threatens sector margins
- Aging demographics boost U.S. healthcare demand
- FDA approvals accelerate driving biotech constituent gains
As of September 22, 2026, the stock is trading at USD 81.95 with a total of 263,068 shares traded. Over the past week, the price has changed by +0.94%, over one month by -2.90%, over three months by +12.81% and over the past year by +26.41%.
Current recommended Stop Loss: 79.30 (which is 3.2% or 2.5 ATR below the current price).
Fidelity Health Care Index has no consensus analysts rating.